Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Jake Liang

Showing results (141-150 of 187) with videos related to

Pageof 19
Sort By:
Gastroenterology|July 6, 2011
Host response to translocated microbial products predicts outcomes of patients with HBV or HCV infectionNetanya G Sandler, Christopher Koh, Annelys Roque, et al.
Mbio|January 11, 2022
Targeting the Fusion Process of SARS-CoV-2 Infection by Small Molecule InhibitorsSeung Bum Park, Parker Irvin, Zongyi Hu, et al.
Journal of Virology|January 25, 2008
Scavenger receptor class B is required for hepatitis C virus uptake and cross-presentation by human dendritic cellsHeidi Barth, Eva K Schnober, Christoph Neumann-Haefelin, et al.
Hepatology (Baltimore, Md.)|June 28, 2003
Maintenance therapy with ribavirin in patients with chronic hepatitis C who fail to respond to combination therapy with interferon alfa and ribavirinJay H Hoofnagle, Marc G Ghany, David E Kleiner, et al.
Hepatology (Baltimore, Md.)|March 30, 2021
The 2020 Nobel Prize for Medicine or Physiology for the Discovery of Hepatitis C Virus: A Triumph of Curiosity and PersistenceMarc G Ghany, Anna S F Lok, Jules L Dienstag, et al.
Journal of Virology|December 15, 2022
Three-Dimensional Reconstruction of the Hepatitis C Virus Envelope Glycoprotein E1E2 Heterodimer by Electron Microscopic AnalysisTapan Kanai, Zongyi Hu, Renbin Yang, et al.
Hepatology Communications|September 24, 2021
Prospective Study of Withdrawal of Antiviral Therapy in Patients with Chronic Hepatitis B after Prolonged Virological ResponseNaveen Gara, Michele M Tana, Meera Kattapuram, et al.
Journal of Hepatology|November 28, 2025
A genome-wide siRNA screen identifies previously unknown proviral and antiviral host factors in HBV infectionXiaoming Cheng, Yuchen Xia, Chen Li, et al.
Journal of Medicinal Chemistry|November 25, 2015
Discovery, Optimization, and Characterization of Novel Chlorcyclizine Derivatives for the Treatment of Hepatitis C Virus InfectionShanshan He, Jingbo Xiao, Andrés E Dulcey, et al.
Hepatology (Baltimore, Md.)|April 29, 2018
Baseline Intrahepatic and Peripheral Innate Immunity are Associated with Hepatitis C Virus Clearance During Direct-Acting Antiviral TherapyHawwa Alao, Maggie Cam, Chithra Keembiyehetty, et al.
Pageof 19

Showing results (141-150 of 187) with videos related to

Sort By:
Pageof 19
Gastroenterology|July 6, 2011
Host response to translocated microbial products predicts outcomes of patients with HBV or HCV infectionNetanya G Sandler, Christopher Koh, Annelys Roque, et al.
Mbio|January 11, 2022
Targeting the Fusion Process of SARS-CoV-2 Infection by Small Molecule InhibitorsSeung Bum Park, Parker Irvin, Zongyi Hu, et al.
Journal of Virology|January 25, 2008
Scavenger receptor class B is required for hepatitis C virus uptake and cross-presentation by human dendritic cellsHeidi Barth, Eva K Schnober, Christoph Neumann-Haefelin, et al.
Hepatology (Baltimore, Md.)|June 28, 2003
Maintenance therapy with ribavirin in patients with chronic hepatitis C who fail to respond to combination therapy with interferon alfa and ribavirinJay H Hoofnagle, Marc G Ghany, David E Kleiner, et al.
Hepatology (Baltimore, Md.)|March 30, 2021
The 2020 Nobel Prize for Medicine or Physiology for the Discovery of Hepatitis C Virus: A Triumph of Curiosity and PersistenceMarc G Ghany, Anna S F Lok, Jules L Dienstag, et al.
Journal of Virology|December 15, 2022
Three-Dimensional Reconstruction of the Hepatitis C Virus Envelope Glycoprotein E1E2 Heterodimer by Electron Microscopic AnalysisTapan Kanai, Zongyi Hu, Renbin Yang, et al.
Hepatology Communications|September 24, 2021
Prospective Study of Withdrawal of Antiviral Therapy in Patients with Chronic Hepatitis B after Prolonged Virological ResponseNaveen Gara, Michele M Tana, Meera Kattapuram, et al.
Journal of Hepatology|November 28, 2025
A genome-wide siRNA screen identifies previously unknown proviral and antiviral host factors in HBV infectionXiaoming Cheng, Yuchen Xia, Chen Li, et al.
Journal of Medicinal Chemistry|November 25, 2015
Discovery, Optimization, and Characterization of Novel Chlorcyclizine Derivatives for the Treatment of Hepatitis C Virus InfectionShanshan He, Jingbo Xiao, Andrés E Dulcey, et al.
Hepatology (Baltimore, Md.)|April 29, 2018
Baseline Intrahepatic and Peripheral Innate Immunity are Associated with Hepatitis C Virus Clearance During Direct-Acting Antiviral TherapyHawwa Alao, Maggie Cam, Chithra Keembiyehetty, et al.
Pageof 19